Lenalidomide

Abstract

Lenalidomide is one of the derivatives of thalidomide which was developed in the 1950s but withdrawn once from the market due to the tragic consequences of teratogenicity. Lenalidomide was developed to minimize the adverse effects of thalidomide. Because of its many immunomodulatory effects, lenalidomide has been used in the treatment of multiple myeloma (MM) and myelodysplastic syndrome (MDS) with many promising results.